Intuitive Surgical, Inc. $ISRG Shares Sold by Armistice Capital LLC

Key Points

• Armistice Capital LLC has reduced its stake in Intuitive Surgical by 40.7%, selling 19,982 shares during the first quarter, now holding a total of 29,058 shares valued at approximately $14.39 million.
• Shares of Intuitive Surgical saw a 0.1% decrease, opening at $473.30, with a market cap of $169.67 billion and a 52-week trading range of $425.00 to $616.00.
• Analyst ratings for Intuitive Surgical reflect a consensus of 13 buy ratings, 6 hold ratings, and 1 sell rating, with an average price target of $595.95.

Armistice Capital LLC lowered its stake in Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 40.7% during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm owned 29,058 shares of the medical equipment provider's stock after selling 19,982 shares during the period. Armistice Capital LLC's holdings in Intuitive Surgical were worth $14,392,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the stock. Castleark Management LLC boosted its stake in shares of Intuitive Surgical by 3.4% in the fourth quarter. Castleark Management LLC now owns 90,469 shares of the medical equipment provider's stock valued at $47,221,000 after buying an additional 2,990 shares in the last quarter. Arlington Trust Co LLC boosted its stake in shares of Intuitive Surgical by 34.5% in the first quarter. Arlington Trust Co LLC now owns 745 shares of the medical equipment provider's stock valued at $369,000 after buying an additional 191 shares in the last quarter. Aveo Capital Partners LLC boosted its stake in shares of Intuitive Surgical by 37.4% in the first quarter. Aveo Capital Partners LLC now owns 727 shares of the medical equipment provider's stock valued at $390,000 after buying an additional 198 shares in the last quarter. Aaron Wealth Advisors LLC boosted its stake in shares of Intuitive Surgical by 3.2% in the first quarter. Aaron Wealth Advisors LLC now owns 2,509 shares of the medical equipment provider's stock valued at $1,243,000 after buying an additional 78 shares in the last quarter. Finally, Longbow Finance SA boosted its stake in shares of Intuitive Surgical by 132.0% in the first quarter. Longbow Finance SA now owns 19,699 shares of the medical equipment provider's stock valued at $9,756,000 after buying an additional 11,209 shares in the last quarter. Institutional investors and hedge funds own 83.64% of the company's stock.

Analyst Upgrades and Downgrades

ISRG has been the topic of a number of analyst reports. BTIG Research lifted their price target on Intuitive Surgical from $566.00 to $571.00 and gave the company a "buy" rating in a research note on Wednesday, July 23rd. Citigroup restated a "buy" rating and issued a $650.00 price target (up from $590.00) on shares of Intuitive Surgical in a research note on Thursday, May 22nd. UBS Group boosted their target price on Intuitive Surgical from $547.00 to $585.00 and gave the stock a "neutral" rating in a research report on Wednesday, July 23rd. Deutsche Bank Aktiengesellschaft reiterated a "sell" rating on shares of Intuitive Surgical in a research report on Friday, August 22nd. Finally, Truist Financial boosted their target price on Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a research report on Wednesday, July 23rd. Thirteen equities research analysts have rated the stock with a Buy rating, six have issued a Hold rating and one has issued a Sell rating to the company's stock. According to data from MarketBeat.com, Intuitive Surgical presently has an average rating of "Moderate Buy" and an average price target of $595.95.

Insider Activity

In related news, insider Gary S. Guthart sold 2,800 shares of the company's stock in a transaction on Monday, July 28th. The stock was sold at an average price of $495.24, for a total value of $1,386,672.00. Following the completion of the transaction, the insider directly owned 18,520 shares in the company, valued at approximately $9,171,844.80. This represents a 13.13% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Myriam Curet sold 4,500 shares of the company's stock in a transaction on Friday, July 25th. The shares were sold at an average price of $492.48, for a total value of $2,216,160.00. Following the completion of the transaction, the executive vice president owned 353 shares of the company's stock, valued at $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 15,839 shares of company stock worth $7,896,972 over the last three months. 0.70% of the stock is currently owned by corporate insiders.

Intuitive Surgical Stock Down 0.1%

Shares of NASDAQ:ISRG opened at $473.30 on Friday. Intuitive Surgical, Inc. has a 52-week low of $425.00 and a 52-week high of $616.00. The stock's fifty day simple moving average is $500.45 and its 200-day simple moving average is $517.51. The company has a market capitalization of $169.67 billion, a P/E ratio of 66.01, a P/E/G ratio of 4.96 and a beta of 1.59.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings data on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The business had revenue of $2.44 billion for the quarter, compared to the consensus estimate of $2.35 billion. During the same period in the prior year, the business earned $1.78 earnings per share. The business's revenue was up 21.4% on a year-over-year basis. On average, sell-side analysts anticipate that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

Want to see what other hedge funds are holding ISRG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.